The Financial Post reports in its Thursday edition that the rise of weight-loss drugs in Canada and the United States is a demand driver for AGT Foods's protein-packed pasta, said the company's chief executive officer Murad Al-Katib. Postmedia's Nykole King writes that the Regina company is betting that it won't be a short-lived craze as it rolls out more protein-rich products to store shelves. These products helped boost gross profits, partially offsetting a revenue hit partly from the Iran war, AGT Foods said as it reported second quarter earnings Monday. Health Canada recently approved a generic semaglutide injection, slashing the retail price of the GLP-1 receptor agonist by about one-third. Al-Katib said this could have a knock-on effect for his business as shoppers prioritize more intake of protein and dietary fibre. "The affordability of GLP1 means, in my mind, we're at the beginning of this trend," Mr. Al-Katib told Postmedia after the company's second quarter earnings call. An estimated three million Canadians and more than 28 million Americans are taking the prescription. The drug is "likely influencing grocery baskets" to be filled with more protein-rich foods, according to Leger's survey of GLP-1 users.